Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Might be

<< Previous

Bullboard Posts

Next >>

Comment by bmk211on Dec 05, 2024 4:54pm

224 Views

Post# 36348067

RE:RE:RE:Might be

The FDA who currently is funded by big pharma and approves drugs like vioxx known to kill people for 5 years before being pulled. And the FDA who has been untouchable because no one would stand up to them. Let's keep it that way. Maybe write a letter to Trump and Kennedy ask them to keep it staus quo. Keep the FDA unchecked and drug approvals to those with the deepest pockets.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features